AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 92 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $39,000 | -84.3% | 109,683 | -68.2% | 0.00% | – |
| Q1 2022 | $249,000 | -49.3% | 345,200 | +854.8% | 0.00% | – |
| Q2 2020 | $491,000 | +334.5% | 36,154 | +162.3% | 0.00% | – |
| Q1 2019 | $113,000 | +10.8% | 13,786 | +100.1% | 0.00% | – |
| Q4 2017 | $102,000 | +1175.0% | 6,888 | +683.6% | 0.00% | – |
| Q1 2017 | $8,000 | -11.1% | 879 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | +12.5% | 879 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | -81.4% | 879 | -84.8% | 0.00% | – |
| Q2 2016 | $43,000 | -87.7% | 5,779 | -85.1% | 0.00% | -100.0% |
| Q1 2016 | $349,000 | +100.6% | 38,779 | +187.7% | 0.00% | – |
| Q4 2015 | $174,000 | -57.8% | 13,479 | -68.4% | 0.00% | -100.0% |
| Q3 2015 | $412,000 | – | 42,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |